北大醫藥(000788.SZ):持股5%以上股東合成集團存在被強制平倉導致被動減持的風險
格隆匯5月12日丨北大醫藥(000788.SZ)公佈,近日收到持股5%以上股東西南合成醫藥集團有限公司轉發的中泰證券《關於信用賬户融資合約到期的提示函》,獲悉合成集團在中泰證券的信用賬户存在被強制平倉導致被動減持的風險。
合成集團通過中泰證券信用賬户參與融資融券業務持有上市公司14.14%股份。合成集團在中泰證券信用賬户的融資合約將於2023年5月15日到期,如合成集團未在合約到期日前按照融資融券合同約定償還融資債務,中泰證券將對合成集團信用賬户實施強制平倉以了結全部融資合約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.